Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-clinical joint disease in psoriasis and imaging response to ustekinumab
ISRCTN18043449Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, open-label trial in plaque psoriasis and psoriatic disease comparing Ustekinumab with Methotrexate (2 arms). Started Oct 2012; status: completed.
02
Drugs
ustekinumabmethotrexate
03
Conditions
plaque psoriasispsoriatic disease
Beyond the preview
Go deeper on ISRCTN18043449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18043449.